EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heterogeneous entity representation for medicinal synergy prediction

Jiawei Wu, Jun Wen iD, Mingyuan Yan, Anqi Dong iD, Shuai Gao, Ren Wang, Can Chen iD

Bioinformatics · 2024

DOI: 10.1093/bioinformatics/btae750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, 2024. Verfasst von Jiawei Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, National University of Singapore, Singapore 119077, Singapore. Hauptthemen laut MEDLINE: Drug Synergism, Computational Biology, Drug Discovery, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Forecasting the synergistic effects of drug combinations facilitates drug discovery and development, especially regarding cancer therapeutics. While numerous computational methods have emerged, most of them fall short in fully modeling the relationships among clinical entities including drugs, cell lines, and diseases, which hampers their ability to generalize to drug combinations involving unseen drugs. These relationships are complex and multidimensional, requiring sophisticated modeling to capture nuanced interplay that can significantly influence therapeutic efficacy. Results We present a novel deep hypergraph learning method named Heterogeneous Entity Representation for MEdicinal Synergy (HERMES) prediction to predict the synergistic effects of anti-cancer drugs. Heterogeneous data sources, including drug chemical structures, gene expression profiles, and disease clinical semantics, are integrated into hypergraph neural networks equipped with a gated residual mechanism to enhance high-order relationship modeling. HERMES demonstrates state-of-the-art performance on two benchmark datasets, significantly outperforming existing methods in predicting the synergistic effects of drug combinations, particularly in cases involving unseen drugs. Availability and implementation The source code is available at https://github.com/Christina327/HERMES.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug SynergismComputational BiologyDrug DiscoveryAntineoplastic AgentsHumansNeural Networks, ComputerNeoplasmsDeep Learning

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Medicine, National University of Singapore, Singapore 119077, Singapore.
  • Harvard Medical School, Harvard University, Boston, MA 02115, United States.
  • Division of Decision and Control Systems and Department of Mathematics, KTH Royal Institute of Technology, Stockholm SE-100 44, Sweden.
  • Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
  • Department of Electrical and Computer Engineering, Illinois Institute of Technology, Chicago, IL 60616, United States.
  • School of Data Science and Society, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.

ORCID-Profile: Jun Wen, Anqi Dong, Can Chen

Zitieren

APA

Wu, J., Wen, J., Yan, M., Dong, A., Gao, S., Wang, R., & Chen, C. (2024). Heterogeneous entity representation for medicinal synergy prediction. Bioinformatics. https://doi.org/10.1093/bioinformatics/btae750

Vancouver

Wu J, Wen J, Yan M, Dong A, Gao S, Wang R, et al. Heterogeneous entity representation for medicinal synergy prediction. Bioinformatics. 2024. doi:10.1093/bioinformatics/btae750

BibTeX
@article{Wu2024,
  author = {Wu, Jiawei and Wen, Jun and Yan, Mingyuan and Dong, Anqi and Gao, Shuai and Wang, Ren and Chen, Can},
  title = {Heterogeneous entity representation for medicinal synergy prediction},
  journal = {Bioinformatics},
  year = {2024},
  doi = {10.1093/bioinformatics/btae750}
}
Kostenlos starten →